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Abstract
Background: An increased interest is given to the impact of high fat diet on health worldwide. Abnormalities in
lipid metabolism induced by high cholesterol diet (HCD) were reported to exacerbate renal diseases via oxidative
stress pathways. Rutin and ascorbic acid showed a protective role against oxidative stress-mediated diseases.
Furthermore, both lipid metabolism and tissue response to oxidative stress damage was found to vary according
to animal gender. Thus, the objective of this work was to examine possible gender-related differences and the
possible protective effects of rutin and ascorbic acid supplementation on high cholesterol diet induced
nephrotoxicity.
Methods: 96 young male and female Wistar albino rats were used. HCD supplemented animals were treated with
rutin alone or in combination with ascorbic acid for 6 weeks. Creatinine plasma level was estimated. Furthermore,
kidney levels of nucleic acids, total protein, malondialdehyde (MDA), reduced glutathione (GSH), total cholesterol,
and triglycerides were determined. Finally, kidney tissues were used for histopathological examination.
Results: HCD supplementation decreased kidney level of nucleic acids, which was more prominent in female
animals. Both vitamin combination significantly attenuated HCD induced decrease in nucleic acids. Moreover,
kidney level of MDA was significantly altered by HCD in both genders, which was inhibited by rutin and ascorbic
acid alone or in combination in male groups and by both vitamins in female groups. There was a reduction in
kidney level of GSH by HCD, especially in male groups, which was attenuated by rutin and ascorbic acid
combination. Kidney levels of total cholesterol and triglycerides were significantly increased by HCD
supplementation in both genders. Coadministration with rutin and/or ascorbic acid protected from such increase,
which was more obvious in both vitamins combination. Histopathological investigation supported vitamins
protective effect, which was more prominent in male vitamins combination group.
Conclusions: HCD-induced renal injury in female was higher than in male animals, suggesting a better anti-
oxidative stress defense response in male’s kidney. Moreover, the antioxidant and reno-protective effects of rutin
and ascorbic acid were augmented following their combination.
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Introduction
It is well known that lifestyle and diet play a role in the
development of kidney disease. Several studies indicated
that abnormalities in lipid metabolism can often accom-
pany and exacerbate renal disease [1,2]. Hypercholester-
olemia is well-known to be an independent risk factor
for renal injury [3] and to aggravate the pathogenesis of
a variety of clinical and experimental renal diseases
[4-6]. High cholesterol diet (HCD) was found to
increase blood pressure and to induce renal injury [7].
Moreover, many accumulating evidences support the
idea that HCD exacerbates kidney damage in animal
models of kidney disease [8]. Previous data showed that
even a short exposure to HCD supplementation is asso-
ciated with an increase in oxidative stress and renal
inflammation [9]. Indeed, HCD supplementation to ani-
mals was reported to significantly increase kidney oxida-
tive stress parameter and to significantly reduce kidney
antioxidant parameters [10]. Therefore, the inhibition of
oxidative stress under hypercholesterolemic conditions
is considered to be an important therapeutic approach
for kidney related diseases.
Rutin (RT), a quercetin-3-rutinosid or vitamin-P, is
considered as one of flavonoid glycosides, which is
found in onions, apples, tea and red wine [11]. Rutin is
well known to exhibit multiple pharmacological activ-
ities including antibacterial, antitumor, anti-inflamma-
tory, anti-diarrheal, antiulcer, anti-mutagenic,
vasodilator and immunomodulator [12]. Furthermore,
rutin showed an inhibitory effect against membrane
lipid peroxidation [13]. Rutin was found to have renal-
protective effects via its antioxidant activities which sug-
gest its protective role in oxidative stress-mediated dis-
eases [13-15]. Vitamin C is a water-soluble enzyme
cofactor, abundantly present in different plants and
some animals. It is present in two chemical forms: the
reduced form (ascorbic acid; AA) and the oxidized form
(dehydroascorbic acid; DHA). AA is the most predomi-
nant form in the human body and is involved in tissue
growth and repair. AA has a potent antioxidant activity
and is well known to protect tissues from oxidative
injury through efficiently quenching the damaging free
radicals produced by many biological processes [16,17].
Gender difference currently plays an important role in
the etiology of hyperlipidaemic-induced disorder includ-
ing cardiovascular diseases (CVD). For instance, men
are more susceptible to coronary heart disease than age-
matched women. However, postmenopausal women
have an equal chance of CVD with men [18,19]. The
underlying mechanisms for this difference are related to
the known effects of estrogens of lipid metabolism, such
as a decrease in HDL catabolism via a decrease in hepa-
tic lipase activity and an increase in LDL catabolism via
an increase in the number of LDL receptors [20].
Moreover, the severity of oxidative stress tissue damage
and injury may vary according to gender difference.
Hepatic oxidative stress and inflammatory response in
acute uremia after bilateral nephrectomy was shown to
be more significant in female than male rats [21]. Sex
dimorphism in pancreas oxidative stress as response to
HCD was also reported, where female rats were pro-
tected against oxidative damage [22]. Furthermore,
application of chronic mild stress to male and female
rats was shown to induce different oxidative stress and
compensatory responses, which was suggested to be due
to differences in the mechanisms regulating oxidant/
antioxidant pathways [23].
The current study was designed with major two goals;
(1) to investigate gender-related differences in response
to high cholesterol diet induced nephrotoxicity using
Wistar albino rats as an animal model; (2) to evaluate
the potential beneficial effects of rutin and/or ascorbic





Young male and female Wistar albino rats (total animals
= 96 rats) were provided by the Experimental Animal
Care Center (King Saud University, Riyadh, Saudi Ara-
bia). Animals were roughly the same age, weighing 80-
100 grams. Animal environment was maintained under
controlled conditions of temperature (22 ± 1°C), humid-
ity (50-55%), and light (12 h light/dark cycles). All meth-
ods including euthanasia procedure were conducted in
accordance with the Guide for the Care and Use of
Laboratory Animals, Institute for Laboratory Animal
Research, National Institute of Health (NIH Publications
No. 80-23; 1996) and approved by the Ethical Guidelines
of the Experimental Animal Care Center (College of
Pharmacy, King Saud University, Riyadh, Saudi Arabia).
Diet
All animals’ diets were prepared in pellet form by add-
ing test materials in rat chow powder following shade
dry method. Table 1 show diet contents for each group.
All the diets were prepared weekly and shade dried.
During whole experimental period, all groups of animals
were kept on free access to food and water.
Methods
Experimental design and animal grouping
All animals were randomly divided in to eight groups
(six male and six female rats per each group) as follow;
group-1: Control, group-2: RT, group-3: AA, group-4:
RT + AA, group-5: HCD, group-6: RT + HCD, group-7:
AA + HCD, group-8: RT + AA + HCD. The experimen-
tal diets were supplemented for 6 consecutive weeks. At
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end of the 6th week rats were sacrificed by decapitation
and the trunk blood was collected in heparinized tubes.
Both kidneys were dissected and weighed. Kidney tissues
were immediately dipped in liquid nitrogen for 1 min
and then preserved at -75°C (Ultra-low freezer, Environ-
mental Equipment, Cincinnati, Ohio, USA) till analysis.
The plasma was collected after centrifugation at 4,000
rpm for 15 min and stored in freezer at -20°C till
analysis.
Determination of plasma levels of creatinine
Creatinine concentrations were estimated in plasma
samples by using commercially available diagnostic kits
(Human, Wiesbaden, Germany).
Determination of kidney levels of nucleic acids and total
protein
Kidney levels of nucleic acids (DNA and RNA) were
estimated by the method described by Bregman, 1983
[24]. Kidney tissues were homogenized in ice-cold dis-
tilled water and the homogenates were suspended in
10% ice-cold trichloroacetic acid (TCA). Pellets were
extracted with 95% ethanol twice. DNA levels were
determined by treating the nucleic acid extract with
diphenylamine reagent and measuring the intensity of
blue color at 600 nm. For quantification of RNA, the
nucleic acid extract was treated with orcinol reagent
and the green color was recorded at 660 nm on spectro-
photometer (LKB-Pharmacia, Mark II, Ireland). The
modified Lowry method by Schacterle and Pollack [25]
was used to estimate kidney levels of total protein.
Bovine plasma albumin was used as standard.
Determination of kidney levels of MDA
Kidney levels of MDA were estimated as described by
Ohkawa et al., 1979 [26]. Briefly, kidney tissue was
homogenized in aqueous 0.15 M KCl solution to give
10% homogenate. One ml of homogenate was then
mixed with one ml of 10% trichloroacetic acid (TCA)
and centrifuged at 3,000 rpm for 15 min. One ml of
supernatant was suspended into one ml of 0.67% 2-thio-
barbutaric acid. Sample tubes were then placed into a
boiling water bath and kept for 15 min. Samples were
allowed to cool down at room temperature followed by
centrifugation at 3,000 rpm for 15 min. The Optical
density of the clear pink supernatants was measured at
532 nm.
Determination of kidney levels of GSH
The method prescribed by Sediak and Lindsay, 1968
[27] was used to determine the concentration of glu-
tathione (GSH) in the kidney. Briefly, a cross section of
kidney tissue were dissected out and homogenized in
ice-cold 0.02 M ethylenediaminetetraacetic acid (EDTA).
An aliquots of 0.5 mL of tissue homogenate was mixed
with 0.2 M Tris buffer, pH 8.2 and 0.1 mL of 0.01 M
Ellman’s reagent, [5,5’-dithiobis-(2-nitro-benzoic acid)]
(DTNB). Each sample tube was centrifuged at 3,000 g at
room temperature for 15 min. The absorbance of the
clear supernatants was measured using spectrophot-
ometer at 412 nm in one centimeter quarts cells.
Determination of kidney levels of total cholesterol and
triglycerides
Lipids contents of kidney tissues were extracted using
the method described by Folch et al., 1957 [28]. In brief,
kidney tissues were homogenized in 0.15 mol/L of ice-
cold KCl (10% w/w) and lipids were extracted with
chloroform: methanol (2:1). After the extraction and
evaporation, tissue lipids were re-dissolved in isopropa-
nol, and kidney cholesterol and triglyceride levels were
estimated enzymatically by commercially available kits
(Human, Wiesbaden, Germany).
Histopathological evaluation of the kidneys
One half of kidney from control, HCD, RT + HCD, AA
+ HCD and RT + AA + HCD male and female groups
was removed for histopathological examination. Kidney
tissues were fixed in 10% neutral buffered formalin,
embedded in paraffin wax, sectioned at 3 μm, stained
with Hematoxylin and Eosin (H & E) stain and placed
in slides for light microscopic examination. To avoid
any type of bias, the slides were coded and examined by
a histopathologist who was blinded to the treatment
groups. Grading of kidney injury was preformed accord-
ing to Table 2. The degree of the nephrotoxicity was
considered according to the total score of kidney injury
grading where; (0-1) classified as no nephrotoxicity, (2-
Table 1 Diet contents for each group
Group Diet contents
Control rat chow
RT rat chow + 0.2% rutin
AA rat chow + 0.4% ascorbic acid
RT + AA rat chow + 0.1% RT + 0.2% AA
HCD rat chow + 1% cholesterol and 0.5% cholic acid
RT + HCD rat chow + 0.2% RT + 1% cholesterol and 0.5% cholic acid
AA + HCD rat chow + 0.4% AA + 1% cholesterol and 0.5% cholic acid
RT + AA + HCD rat chow + 0.1% RT + 0.2% AA + 1% cholesterol and 0.5% cholic acid
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4) classified as mild nephrotoxicity, (5-7) classified as
moderate nephrotoxicity and (8-10) classified as sever
nephrotoxicity.
Statistical analysis
All data were expressed as mean ± Standard Deviation
(SD). Data were statistically analyzed using one-way
ANOVA followed by Student-Newman-Keuls multiple
comparisons test. The differences were considered sta-
tistically significant at P < 0.05. GraphPad prism pro-
gram (version 5) was used as analyzing software.
Results
Effects on kidney weight
Kidney weights did not show significant difference
between control group and other treated groups in both
male and female animals (Table 3). HCD vitamins trea-
ted male and female groups (RT + HCD, AA + HCD
and RT + AA + HCD) did not have kidney weights that
differ significantly from their respective control vitamins
supplemented male and female groups (RT, AA and RT
+ AA, respectively). Similarly, HCD vitamins treated
male and female groups (RT + HCD, AA + HCD and
RT + AA + HCD) did not show kidney weights that dif-
fer significantly from male and female HCD adminis-
tered groups (Table 3).
Effects on plasma creatinine
Creatinine plasma level in both male and female rats
was not significantly altered at any group as compared
to control groups (Table 4). Furthermore, there was no
significant difference between HCD vitamins treated
male and female animals (RT + HCD, AA + HCD and
RT + AA + HCD) and their respective control vitamins
supplemented groups (RT, AA and RT + AA, respec-
tively). Creatinine plasma level was not significantly dif-
ferent in HCD vitamins treated groups (RT + HCD, AA
+ HCD and RT + AA + HCD) as compared to HCD
administered rats in both male and female groups
(Table 4).
Effects on nucleic acids and total protein
In male groups, kidney levels of both nucleic acids and
total protein were not significantly altered by HCD
administration either alone or with vitamins as com-
pared to control group (Table 5). DNA kidney level was
significantly decreased in HCD vitamins treated male
groups (RT + HCD, AA + HCD and RT + AA + HCD)
as compared to their respective control groups (RT, AA
and RT + AA, respectively), while kidney level of RNA
and total protein were not significantly altered. More-
over, no significant differences were found between
HCD vitamins treated male animals (RT + HCD, AA +
Table 2 Histopathological grading of kidney injury
Type of damage Score
GLOMERULAR DAMAGE:
o None 0
o Less than 25% of glomeruli are involved 1
o 25-50% of glomeruli are involved 2
o 51-75% of glomeruli are involved 3
o More than 75% of glomeruli are involved 4
ACUTE TUBULAR NECROSIS
o None 0
o Less than 25% of renal tubules are involved 1
o 25-50% of renal tubules are involved 2
o 51-75% of renal tubules are involved 3
o More than 75% of renal tubules are involved 4
TUBULOINTERSTITIAL NEPHRITIS
o None 0
o Leukocytes confined within the interstitium 1
o Leukocytes within the interstitium and tubular epithelial cells 2
Table 3 Effect of rutin (RT) and/or ascorbic acid (AA) on
kidney weight in high-cholesterol diet (HCD) fed rats
following 6 weeks of supplementation
Treatment
(in rat chow)
Kidney (g)/100 g body
weight
Male Female
Control 0.75 ± 0.07 0.69 ± 0.05
RT (0.2%) 0.71 ± 0.06 0.70 ± 0.04
AA (0.4%) 0.76 ± 0.04 0.74 ± 0.08
RT (0.1%) + AA (0.2%) 0.78 ± 0.04 0.70 ± 0.04
HCD (1% cholesterol + 0.5% cholic acid) 0.72 ± 0.04 0.73 ± 0.16
RT (0.2%) + HCD 0.72 ± 0.03 0.68 ± 0.04
AA (0.4%) + HCD 0.74 ± 0.07 0.72 ± 0.10
RT (0.1%) + AA (0.2%) + HCD 0.75 ± 0.07 0.74 ± 0.08
Data were expressed as Mean ± S.D and analyzed using one-way ANOVA
followed by Student Newman-Keuls method as post hoc test. Six rats were
used in each group
Table 4 Effect of rutin (RT) and/or ascorbic acid (AA) on
plasma level of creatinine in high-cholesterol diet (HCD)





Control 51.94 ± 12.59 35.59 ± 9.71
RT (0.2%) 49.76 ± 6.94 32.91 ± 14.13
AA (0.4%) 51.21 ± 4.52 35.21 ± 12.03
RT (0.1%) + AA (0.2%) 55.21 ± 2.98 44.77 ± 14.21
HCD (1% cholesterol + 0.5% cholic
acid)
43.95 ± 6.53 36.35 ± 13.88
RT (0.2%) + HCD 54.12 ± 9.29 47.07 ± 16.54
AA (0.4%) + HCD 55.93 ± 20.93 42.10 ± 11.40
RT (0.1%) + AA (0.2%) + HCD 53.39 ± 12.84 37.12 ± 9.79
Data were expressed as Mean ± S.D and analyzed using one-way ANOVA
followed by Student Newman-Keuls method as post hoc test. Six rats were
used in each group
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HCD and RT + AA + HCD) and HCD-fed male group
(Table 5). In female groups, kidney levels of DNA were
significantly reduced in HCD, RT + HCD and AA +
HCD groups as compared to control group. Kidney
RNA levels in female group were also significantly
reduced by HCD administration either alone or in com-
bination with RT and/or AA as compared to control
animals. Such reduction was not demonstrated in total
protein of female groups. Indeed, a significant difference
in both nucleic acids and total protein was found
between RT + HCD as well as AA + HCD treated
female rats and their respective vitamin supplemented
control groups (RT and AA). Combination of rutin and
ascorbic acid with HCD (RT + AA + HCD) in female
group did not show significant difference from RT +
AA group in kidney’s DNA and total protein, while
RNA level was significantly different in these two
groups. There was no significant difference between
HCD female group and HCD supplemented with rutin
and/or ascorbic acid (RT + HCD, AA + HCD and RT +
AA + HCD) in kidney levels of DNA and total protein.
Similar effect was observed in RNA kidney level except
for RT + AA + HCD group, which was significantly dif-
ferent from HCD female group (Table 5).
Effects on MDA and GSH
HCD administration to Wistar albino rats for 6 weeks
significantly elevated kidney level of MDA in HCD male
and female groups as well as in HCD vitamins treated
female groups (RT + HCD, AA + HCD and RT + AA +
HCD) as compared to control groups (Table 6). Kidney
levels of MDA were also significantly high in HCD vita-
mins treated female animals (RT + HCD, AA + HCD
and RT + AA + HCD) as compared to their respective
control vitamins supplemented groups (RT, AA and RT
+ AA), which were not observed in male groups.
Furthermore, HCD groups supplemented with rutin
and/or ascorbic acid (RT + HCD, AA + HCD and RT +
AA + HCD) did not have a significant difference in
Table 5 Effect of rutin (RT) and/or ascorbic acid (AA) on kidney nucleic acids and total protein levels in high-
cholesterol diet (HCD) fed rats following 6 weeks of supplementation
Treatment
(in rat chow)
DNA (μg/100 mg) RNA (μg/100 mg) Total protein (mg/100 mg)
Male Female Male Female Male Female
Control 101.35 ± 18.33 110.56 ± 17.93 266.30 ± 26.60 240.16 ± 19.00 12.21 ± 0.47 11.26 ± 0.63
RT (0.2%) 108.33 ± 24.25 117.22 ± 12.08 271.22 ± 27.50 254.10 ± 11.80 12.15 ± 0.49 11.63 ± 0.43
AA (0.4%) 110.25 ± 18.05 114.21 ± 21.35 278.77 ± 17.28 248.52 ± 13.58 11.84 ± 0.53 11.95 ± 0.24
RT (0.1%) + AA (0.2%) 114.35 ± 17.37 112.60 ± 21.77 269.24 ± 31.53 250.20 ± 13.05 12.20 ± 0.60 11.53 ± 0.56
HCD (1% cholesterol + 0.5% cholic acid) 76.07 ± 15.99 75.64 ± 16.37 a 247.01 ± 13.17 186.95 ± 19.04 a 11.45 ± 0.35 10.64 ± 0.35
RT (0.2%) + HCD 81.45 ± 10.83 b 79.63 ± 12.47 ab 252.52 ± 20.72 192.11 ± 13.22 ab 11.54 ± 0.28 10.80 ± 0.31 b
AA (0.4%) + HCD 79.62 ± 11.54 c 84.46 ± 9.00 ac 255.66 ± 18.87 193.82 ± 20.91 ac 11.76 ± 0.37 10.96 ± 0.15 c
RT (0.1%) + AA (0.2%) + HCD 86.64 ± 11.89 d 102.49 ± 14.25 e 258.09 ± 21.65 219.12 ± 15.86 ade 11.87 ± 0.31 11.15 ± 0.24
Data were expressed as Mean ± S.D and analyzed using one-way ANOVA followed by Student Newman-Keuls method as post hoc test. Six rats were used in
each group. aAll treated groups vs. Control; bRT + HCD vs RT group; cAA + HCD vs AA group; dRT + AA + HCD vs RT + AA group; eRT + HCD, AA + HCD and RT +
AA + HCD vs HCD
Table 6 Effect of rutin (RT) and/or ascorbic acid (AA) on kidney MDA and GSH levels in high-cholesterol diet (HCD) fed
rats following 6 weeks of supplementation
Treatment
(in rat chow)
MDA (mmol/g) GSH (nmol/100 mg)
Male Female Male Female
Control 168.77 ± 22.10 178.80 ± 15.99 131.68 ± 14.04 110.84 ± 18.16
RT (0.2%) 175.40 ± 19.88 184.13 ± 25.61 129.19 ± 9.45 122.87 ± 24.24
AA (0.4%) 164.19 ± 18.62 186.53 ± 25.54 128.14 ± 15.03 125.35 ± 39.96
RT (0.1%) + AA (0.2%) 161.67 ± 12.66 185.44 ± 29.42 126.87 ± 12.26 134.76 ± 15.95
HCD (1% cholesterol + 0.5% cholic acid) 204.91 ± 26.35 a 253.80 ± 15.06 a 94.93 ± 11.91 a 79.56 ± 11.65
RT (0.2%) + HCD 194.50 ± 18.43 235.69 ± 11.26 ab 98.29 ± 9.85 ab 82.71 ± 13.96 b
AA (0.4%) + HCD 182.48 ± 14.50 230.15 ± 13.94 ac 101.28 ± 12.98 ace 91.79 ± 12.32
RT (0.1%) + AA (0.2%) + HCD 164.44 ± 16.49 220.06 ± 16.02 ade 117.71 ± 14.37 e 106.01 ± 19.25
Data were expressed as Mean ± S.D and analyzed using one-way ANOVA followed by Student Newman-Keuls method as post hoc test. Six rats were used in
each group. aAll treated groups vs. Control; bRT + HCD vs RT group; cAA + HCD vs AA group; dRT + AA + HCD vs RT + AA group; eRT + HCD, AA + HCD and RT +
AA + HCD vs HCD
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kidney level of MDA as compared to HCD group in
male animals. In female animals, HCD group supple-
mented with rutin and ascorbic acid (RT + AA + HCD)
expressed significant difference in kidney level of MDA
as compared to HCD group, while (RT + HCD and AA
+ HCD) groups did not show such significant difference
(Table 6). On the other hand, kidney levels of GSH
were significantly decreased in HCD, RT + HCD and
AA + HCD treated male groups, but not RT + AA +
HCD group, as compared to control groups. Such signif-
icant decrease was not seen in female animals. More-
over, RT + HCD and AA + HCD treated male animals
had a significantly reduced level of kidney GSH com-
pared to their control vitamins supplemented groups
(RT and AA, respectively). Female group supplemented
with rutin and HCD was the only HCD vitamin treated
group that had a significantly reduced GSH level in kid-
ney as compared to its respective control vitamin trea-
ted group, RT group. Additionally, concurrent
administration of AA or RT + AA with HCD signifi-
cantly increased GSH kidney level in male groups as
compared to HCD male group. Such effect was not seen
in female groups (Table 6).
Effects on total cholesterol and triglycerides
In both male and female groups, HCD administration
resulted in a significant increase in kidney levels of total
cholesterol in all HCD-supplemented groups (Table 7).
Moreover, kidney levels of total cholesterol in HCD vita-
mins treated male and female animals (RT + HCD, AA
+ HCD and RT + AA + HCD) were significantly differ-
ent from their levels in vitamins supplemented control
groups (RT, AA and RT + AA). In both genders, kidney
level of total cholesterol was significantly low in HCD
vitamins treated groups (RT + HCD, AA + HCD and
RT + AA + HCD) as compared to HCD administered
animals (Table 7). Kidney levels of triglycerides in male
and female groups were significantly increased in HCD,
RT + HCD and AA + HCD groups as compared to con-
trol groups. However, triglycerides were no significantly
different in RT + AA + HCD and control groups in
both male and female animals. In both male and female
animals, there was a significant difference in kidney
levels of triglycerides in RT + HCD and AA + HCD
groups and their vitamins treated control animals in RT
and AA groups, respectively. However, male and female
rats’ kidney level of triglycerides was significantly low in
HCD vitamins treated groups (RT + HCD, AA + HCD
and RT + AA + HCD), except in HCD + RT male
group, as compared to HCD groups of rats (Table 7).
Histopathological evaluations
In male groups, histopathological examination revealed;
(1) normal cortical and medullary pattern with well-
formed glomeruli in control group, (2) hypercellular glo-
meruli with mesangeal cells proliferation till occlusion of
glomeruli and few shrink as well as a swelling in tubular
epithelial cells in HCD group, (3) proliferated hypercel-
lular glomeruli with mesangial cells proliferation along
with some swollen epithelial cells and no interstitial
inflammatory cells in RT + HCD group, (4) hypercellu-
lar glomeruli with mesangeal cell proliferation and occa-
sional some shrinked glomeruli with no
tubulointerstitial inflammatory cells in AA + HCD
group, (5) a preserved cortex and medulla with pre-
served normal looking glomeruli surrounded by benign
tubules with slight swollen epithelail cells of some
tubules in RT + AA + HCD group (Table 8 and Addito-
nal file 1: Table S1). In female groups, histopathological
examination revealed; (1) normal looking glomeruli with
glomerular capillaries with no tubulointerstitial cell infil-
trate in control group, (2) considerable number of
hypercellular glomeruli with mesangeal proliferation of
more than 50% along with tubular dilatation containing
Table 7 Effect of rutin (RT) and/or ascorbic acid (AA) on kidney Total Cholesterol and Triglycerides levels in high-
cholesterol diet (HCD) fed rats following 6 weeks of supplementation
Treatment
(in rat chow)
Total Cholesterol (mg/g wet tissue) Triglycerides (mg/g wet tissue)
Male Female Male Female
Control 13.58 ± 1.72 16.75 ± 1.39 6.14 ± 0.94 6.42 ± 0.82
RT (0.2%) 12.99 ± 1.36 16.64 ± 1.24 6.29 ± 1.02 6.35 ± 1.10
AA (0.4%) 12.36 ± 1.12 16.42 ± 1.44 6.11 ± 0.80 6.18 ± 0.70
RT (0.1%) + AA (0.2%) 12.33 ± 0.46 16.72 ± 1.10 5.83 ± 0.54 6.00 ± 0.77
HCD (1% cholesterol + 0.5% cholic acid) 24.86 ± 2.80 a 32.66 ± 4.53 a 10.11 ± 1.11 a 13.46 ± 1.19 a
RT (0.2%) + HCD 21.87 ± 2.02 abe 27.69 ± 2.18 abe 9.40 ± 1.04 ab 10.95 ± 1.96 abe
AA (0.4%) + HCD 19.43 ± 0.83 ace 23.28 ± 2.51 ace 7.90 ± 0.59 ace 8.45 ± 0.69 ace
RT (0.1%) + AA (0.2%) + HCD 16.99 ± 1.41 ade 20.59 ± 2.89 ade 6.19 ± 0.83 e 7.38 ± 0.78 e
Data were expressed as Mean ± S.D and analyzed using one-way ANOVA followed by Student Newman-Keuls method as post hoc test. Six rats were used in
each group. aAll treated groups vs. Control; bRT + HCD vs RT group; cAA + HCD vs AA group; dRT + AA + HCD vs RT + AA group; eRT + HCD, AA + HCD and RT +
AA + HCD vs HCD
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hyaline casts and epithelial swelling as well as few foci of
tubulointerstitial inflammatory cell in HCD group, (3)
scattered few hypercellular glomeruli with mesangeal
cell proliferation as well as few eosinophilic hyaline
casts within some tubules in RT + HCD group, (4) scat-
tered hypercellular glomeruli less than 25% of glomeruli
as well as few scattered tubulointerstitial cell infiltrates
and few swollen epithelial cells of tubular epithelium in
AA + HCD group, (5) in RT + AA + HCD group scat-
tered few hypercellular glomeruli with mesangeal cell
proliferation along with scattered few tubules containing
eosinophilic hyaline casts with swollen epithelial cell lin-
ing (Table 8 and Additonal file 1: Table S1).
Discussion
The effects of dietary rutin and/or ascorbic acid on high
cholesterol diet (HCD) induced-nephrotoxicity in male
and female Wistar albino rats were investigated. HCD
administration for six consecutive weeks induced renal
injury and nephrotoxicity, which was more in female
than in male animals. Moreover, rutin and ascorbic acid
were found to protect from HCD induced-nephrotoxi-
city. In addition, these nephro-protective effects were
improved in our study by administration of both vitamins
in combination to the HCD fed rats which was supported
by results from histopathological investigation.
HCD is well known to cause nephrotoxicity and renal
injury in different animal models. In the present study,
signs of increased renal oxidative damage induced by
HCD supplementation for six weeks were studied. Mean
kidney weights were not significantly changed after
HCD feeding and these results are in agreement with
earlier reports [29,30]. This may be because of HCD
could not alter the body weights significantly. Plasma
creatinine levels also remained same in HCD group as
compared to control animals. Similar results are
reported by Kasiske et al. (1990) that, HCD supplemen-
tations to rats did not change the creatinine levels
although kidney injury was reported [29]. Moreover,
HCD feeding for eight weeks could not significantly
altered the plasma creatinine levels in rats [31]. In our
study, HCD administration to male as well as female
rats resulted in moderate degree of nephrotoxicity as
confirmed by the histopathological investigation. Treat-
ment with HCD for six weeks significantly altered kid-
ney levels of total cholesterol and triglycerides.
Moreover, kidney level of MDA, a specific lipid peroxi-
dation marker, was elevated while GSH level was
decreased after six weeks of HCD diet administration to
rats. Previous data showed HCD administration to cause
hyperlipidemia and to be associated with oxidative stress
and nitric oxide inactivation by ROS, which diminishes
nitric oxide (NO) bioavailability leading to renal dys-
function [32]. Furthermore, HCD elevated brain, kidney
and erythrocytes levels of lipid peroxidation products
while decreased GSH content [33]. It was reported that
HCD induces modification in lipid composition of cell
membranes and the extracellular matrix to be more
prone to free radical generation [34]. Therefore, we sug-
gest that HCD induced-nephrotoxicity reported in our
study were due to increased rate of oxidative stress and
lipid peroxidation in the kidneys, which are kwon to
potentiate generation of reactive oxygen species (ROS)
and renal injury.
The present study also showed that HCD can induce
more significant renal impairment and toxicity in female
than male animals. This suggests that male antioxidant
defense response to HCD-induced neohrotoxicity was
higher than female response. It is well known that sex-
ual steroid hormones can control many physiological
and pathophysiological processes [35]. Sexual hormones
have a selective influence on gene transcription and
RNA production, which explain their regulation of the
biosynthesis of specific proteins [36]. Therefore, these
hormones can regulate endogenous pattern of antioxi-
dant defense enzyme expression. Several studies have
demonstrated the sexual dimorphism in the activity of
antioxidant defense enzymes in different rat tissues
[37-41]. One study conducted by Capel and Smallwood
[42] did not find a noteworthy difference in glutathione
peroxidase (GSH-Px), one of the antioxidant endogen-
ous enzyme, activity in the brain between males and
Table 8 Histopathological scoring of glomerular damage, acute tubular necrosis, tubulointerstitial nephritis as well as
degree of nephrotoxicity after rutin (RT) and/or ascorbic acid (AA) treatments in high-cholesterol diet (HCD) fed rats











Male Female Male Female Male Female Male Female Male Female
Control 1 0 0 1 0 1 1 1 No No
HCD (1% cholesterol + 0.5% cholic acid) 2 2 3 2 1 2 6 6 Moderate Moderate
RT (0.2%) + HCD 1 1 1 1 0 0 2 2 Mild Mild
AA (0.4%) + HCD 2 1 1 0 0 1 3 2 Mild Mild
RT (0.1%) + AA (0.2%) + HCD 0 1 0 1 0 0 0 2 No Mild
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females, while in the liver the activity of this enzyme
was significantly higher in females than in males. Similar
results on the liver GSH-Px activity were noticed by in
Prohaska and Sunde study [37]. Interestingly, Finley and
Kincaid [43] reported that plasma and kidney cytosol
selenium content, an endogenous antioxidant, and GSH-
Px activity were increased in male compared to the
same tissues in female animals, although both were
increased in female liver cytosol than male. Experimen-
tal data confirmed that males exhibited significantly
higher levels of endogenose antioxidant defense para-
meters in kidney such as Mn, Cu, Zn, SOD, glutathione
peroxidase, and catalase than females [44]. Therefore,
higher basal levels of ROS are measured by lucigenin
chemiluminescence in the renal courtex of females [44].
Furthermore, total renal superoxide dismutase and cata-
lase activities were found to be higher in male sponta-
neously hypertensive rats than females [44]. These
findings are in agreement with our study results as male
rats showed more renal antioxidant defense response to
HCD-induced increase in MDA and decrease in RNA
and total protein than did female rats.
One possible explanation of the degree of renal oxida-
tive damage observed in female rats is that females are
able to oxidize poly unsaturated fatty acids more than
males. High fat diet was reported to reduce testosterone
and to increase estrogen serum levels, which was asso-
ciated with increased intra-abdominal fats in male than
in female [32]. That is why exogenous treatment of
ovariectomized rats with estrogen was shown to limit
the ovariectomy-induced increase of adiposity [45]. In
one study, male, but not female, rats showed a signifi-
cant negative correlation with adipose poly unsaturated
fatty acids content, which suggests that poly unsaturated
fatty acids metabolism and oxidation is higher in female
than in male [32]. This high rate of lipid metabolism
and oxidation could influence more lipid peroxidation
and generation ROS. Another possible mechanism is
that estrogen itself is able to induced oxidative stress
[46]. It was reported that, interaction between estrogen
and its receptor (ER) involves an oxidative stress-
mediated pathway [47]. Some studies indicate that estro-
gen exposition damages DNA under acute conditions in
cell culture, which was more significant in ER positive
cells [47,48]. Moreover, Wellejus and Loft 2002, sug-
gested that the mechanism of estrogen induced oxida-
tive stress may involve second messenger systems at
which estrogen can bound to its cellular receptor and
then transported to estrogen-sensitive genes in the
nucleus, where redox cycling may take place [49].
In the present study, HCD induced renal impairment
was significantly attenuated by administration of rutin
and ascorbic acid. Our results revealed that the combi-
nation of both vitamins could have an additive, or
sometimes synergistic, antioxidant effects. These specu-
lations are supported by the histopathological evaluation
that showed rutin and ascorbic acid combination to pre-
vent HCD-induced nephrotoxicity especially in male
animals. Flavonoids such as rutin are now widely
accepted as physiologic antioxidants which are known
to have effective free radical scavenging activity [50-52].
Previous data reported rutin, or vitamin P, to decrease
the permeability of capillaries, scavenge free radicals,
lower hepatic and blood cholesterol levels, and have
antiplatelet activity [15,53,54]. Vitamin C (ascorbic acid)
is a promising and effective agent in treating and pre-
venting of allergic rhinitis [55], diabetes [56], heart dis-
ease [57] and cancer [58]. Measurements of kidney level
of nucleic acids revealed that rutin and ascorbic acid
combination can prevent renal cytotoxic damage
induced by HCD supplementation to the rats. However,
kidney level of total cholesterol results showed that both
vitamins had a reno-protective effect that was similar
when they were supplemented alone or in combination.
Furthermore, HCD induced elevation in kidneys trigly-
ceride was significantly attenuated by vitamins combina-
tion with an extent that was much better than
administration of each vitamin alone. ROS are well
known to induce cyto-toxicity and their action on unsa-
turated fatty acids has been implicated in the pathogen-
esis of various diseases [15]. Several studies reported
both rutin and ascorbic acid to have a potent ability to
damage free radicals produced through biological pro-
cesses in many extracellular and intracellular reactions
[15,59]. Therefore, we suggest that the combined renal
cyto-protective effects of both rutin and ascorbic acid
are due to their free radical scavenging capability which
seems to be increased by both vitamins combination.
In addition, both vitamins combination significantly
decreased MDA and elevate GSH kidney levels as com-
pared to their altered levels in HCD group suggesting
that the antioxidant properties of rutin may be attribu-
ted to its protective effects on lipid peroxidation. Rutin
can augment cellular antioxidant defense mechanisms
leading to the protection against oxidative tissue injury
[15]. Rutin metabolism, inside the intestines by micro-
flora, results in formation of its aglycone quercetin,
which is responsible for rutin’s in vivo antioxidant activ-
ity [60]. Previous data showed that rutin possess mem-
brane lipid peroxidation inhibitory effects [13].
Furthermore, rutin was reported to increase the antioxi-
dant capacity in the kidney of normal rats as well as in
a liposomal model [61,62]. Rutin can prevent lipid per-
oxidation by chelating metal ions such as ferrous cations
[60]. These ions are involved in the so called Fenton
reaction, which generates ROS leading to lipid peroxida-
tion. Interestingly, when red wine, which is known to
contain rutin as one of its main components, was
Al-Rejaie et al. Lipids in Health and Disease 2012, 11:41
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supplemented with HCD for 4 weeks, total cholesterol
and lipid peroxidation products in the brain, kidney and
erythrocytes were significantly decreased compared with
the high-cholesterol diet alone, while GSH content and
antioxidative enzymes activities were enhanced [33]. In
parallel, vitamin C functions as an electron donor to
protect the body from radicals and pollutants [63,64]. A
study conducted by Grajeda-Cota et al. [65] reported
that the extracellular ascorbic acid can scavenge ROS
derived by the oxidation-reduction cycle which pro-
tected from tissue damages. Vitamin C is reported to
improve diabetic nephro- and retino-pathy through its
ability to induce remission of lipid peroxidation and
lipid metabolism abnormalities in adult rats [59]. Indeed,
the protection against of oxidative modification of pro-
teins and the alteration in endogenous antioxidants
activities such as glutathione might be trough the che-
lating property of vitamin C to react with free radicals
or with highly reactive by products of lipid peroxidation
[66].
Conclusion
Taken together, we suggest that HCD can induce
nephrotoxicity with higher extent in female than in
male animals, suggesting a more antioxidant defense
mechanism in kidneys of male than female animals.
Moreover, we concluded that combining rutin and
ascorbic acid can augmented their ability to attenuate
ROS-induced lipid peroxidation which prevented HCD
induce renal injury in Wistar albion rats.
Additional material
Additional file 1: Table S1. Effect of rutin (RT) and/or ascorbic acid (AA)
on kidney histopathological evaluation in high-cholesterol diet (HCD) fed
rats following 6 weeks of supplementation.
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